Published in AIDS Weekly, December 18th, 2006
Napo is targeting approval of crofelemer for HIV/ AIDS (CRO-HIV) in 2008. The crofelemer API is manufactured by Glenmark Pharmaceuticals Ltd. at a dedicated unit at its U.S. Food & Drug Administration approved facility in Ankleshwar, India.
Glenmark is also the licensee of crofelemer from Napo for the indications of adult acute infectious diarrhea (CRO-ID), pediatric diarrhea (CRO-PED) and HIV/AIDS related diarrhea in approximately 140...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.